Status:
UNKNOWN
Explore the Advantages of Remimazolam Used on Gastroscopy
Lead Sponsor:
Sichuan Provincial People's Hospital
Conditions:
Induction of Anesthesia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
There are many different types of intravenous anesthetics used in gastroscopy, but each type of drug has its advantages and disadvantages,remimazolam is a novel ultra-short-acting benzodiazepine with ...
Detailed Description
Sedation for gastroscopy is still a topic of debate in the global anesthesia and gastroenterology communities, and the sedation protocols of anesthesiologists and endoscopists vary widely. There are m...
Eligibility Criteria
Inclusion
- Patients who are to undergo painless gastroscopy
- Patients aged 18 - 80 years, regardless of gender
- 18 \< BMI \< 30 kg/m2.
- American Society of Anesthesiologists (ASA) classification of I-III.
Exclusion
- Preoperative hypertensive patients \>180/110 mm Hg or hypotensive patients \<80/50 mm Hg.
- Heart rate \<50 beats/min.
- A history of acute inflammation of the respiratory tract that has not been cured within 2 weeks; severe metabolic diseases of the heart, brain, lungs, liver, kidneys and diabetes mellitus; previous heart attack, severe myocardial, ischemia, severe atrioventricular block
- Those who may have or have had a difficult airway or a history of recovery from abnormal surgical anesthesia
- Patients with significant electrolyte disturbances such as hyperkalemia
- Patients with a history of long-term use of immunosuppressive agents such as hormones or adrenal cortical suppression
- Patients with known allergy to emulsions and opioids
- Those with combined use of other sedative and analgesic drugs within the preoperative period (including injections, oral and use of related proprietary Chinese medicines)
- Those suspected of abusing narcotic analgesics or sedatives
- Those who have neuromuscular system diseases, mental diseases, etc. who do not cooperate and cannot communicate.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT05429086
Start Date
June 1 2022
End Date
August 1 2022
Last Update
June 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.